Journals / Journal of Neurological Sciences (Turkish) / 2008 / Cilt: 25 - Sayı: 2

Sex hormone levels during and between attacks at female migraine patients

Migrenli kadın hastalarda atak sırasında ve ataklar arası dönemde seks hormon düzeyleri

Pages
84–91
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were no differences in all other sex hormones levels between headache attack and interval period (absolute value; t

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The objective of our study is to investigate the relation between the serum levels of sex hormones and migraine headache in female migraine patients.
📊
Key Findings & Data:Materials and Methods: 46 female migraine patients who had no systemic disease were enrolled in this study.
💡
Conclusion & Impact:There were no differences in all other sex hormones levels between headache attack and interval period (absolute value; t
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: The objective of our study is to investigate the relation between the serum levels of sex hormones and migraine headache in female migraine patients. Serum levels of estrogen, progesterone, follicle stimulating hormone, luteinizing hormone and prolactine were measured during the headache attack and in the interval period in female migraine patients with or without aura. Materials and Methods: 46 female migraine patients who had no systemic disease were enrolled in this study. The patients ranging in age from 15 to 45 years. Blood samples were taken from the patients during the headache attack and in the interval period. We measured the serum level of estrogen, progesterone, follicle stimulating hormone, luteinizing hormone and prolactine.Results: The serum level of estrogen during the headache attack were significantly lower than the interval period level (absolute value; t>1.96). There were no differences in all other sex hormones levels between headache attack and interval period (absolute value; t

Özet

Amaç: auralı ve aurasız migren tanısı almış kadın hastalarda, migren atağı sırasında ve ataklar arası dönemde serum östrojen, progesteron, folikül stimülan hormon, luteinizan hormon ve prolaktin hormon düzeyleri ile baş ağrısı ve aura durumu arasındaki ilişkinin değerlendirilmesi. Materyal ve Metod: Başağrısı Polikliniğinde, 15-45 yaş arasında migren tanı kriterlerine uyan ve sistemik herhangi bir hastalığı olmayan 46 kadın hasta alındı. Hastalardan, atak sırasında ve ataklar arası dönemde olmak üzere kan alındı. Serumda Östrojen,Progesteron, LH, FSH ve Prolaktin hormonu düzeyleri ölçüldü.Results: 46 hastanın atak sırasında ve ataklar arası dönemde ölçülen hormon değerlerine bakıldığında, atak sırasında estradiol hormonu anlamlı derecede düşük bulunmuştur(mutlak değer t>1,96).Diğer hormonlarda istatistiksel olarak anlamlı fark bulunmamıştır(mutlak değer t

🔖

Cite This Article

TİRELİ, H., ÇETİNKAYA, Y., TÜRKOĞLU, R., DEMİRKAYA, M., KURTULMUŞ, Y. Ş. (2022). Sex hormone levels during and between attacks at female migraine patients. Journal of Neurological Sciences (Turkish), Cilt: 25 - Sayı: 2, 84–91. https://ajindex.com/articles/565584

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Beckham JC, Krug LM, Penzien DB. The relationship of ovarian steroids, headache activity and menstruel distress: a pilot study with female migraineurs. Headache 1992; 32:292-297
  2. Cassidy EM, Tomkins E, Sharifi N, Dinan T, Hardiman O, O'Keane V. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone. Pain. 2003 Feb; 101: 283-90 3) Cavestro C, Rosatello A, Marino MP, Micca G, Asteggiano G. High prolactin levels as a worsening factor for migraine. J Headache Pain. 2006 Apr; 7: 83-9 4) Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparitive study between migraine with aura and migraine without aura. Cephalgia 1995; 15: 140-4
  3. Epstein MT, Hockaday JM,Hockaday TD. Migraine and reproductive hormones throughout the menstruel cycle. Lancet 1975; 1: 543-48
  4. Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Nappi G. Migraine with aura and reproductive life events: a case control study. Cephalgia 2000; 20: 701-7
  5. Kaiser HJ, Meienberg O. Deterioration of onset of migraine under estrogen replacement therapy in the menopause. J Neurol Neurosurg Psychiatry 1993; 240: 195-97
  6. MacGregor EA, Frith A, Ellis J, Aspinall L, Estrogen ‘withdrawal': a trigger for migraine? A double-blind placebo-controlled study of estrogen supplements in the late luteal phase in women with migraine. Cephalgia 2003; 23:684
  7. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22:355-65
  8. Somerville BW. The role of progesterone in menstrual migraine. Neurology 1971; 21: 853-59.